Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022
View
Metabolism, Alcohol & Toxicity
5
Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022
View
General Hepatology
1
Alexion: Wilson Disease in Neurology, Hepatology and Psychiatry: The Great Chameleon - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
1
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022
View
Immune-Mediated and Cholestatic Diseases
1
Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey - ILC 2022
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
General Hepatology
6
Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019
